Several mechanisms that may account for the improved immune response have been described such as increased MDA expression on melanoma cells and decreased intra-tumoral VEGF production, others remain speculative, such as increased cross presentation to DCs resulting from BRAF/MEK inhibition-mediated necrosis/apoptosis of melanoma cells. Here, MAP2K7 is linked to melanoma.